Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Transgenic Operative Products

Transgenic Operative Products
2006 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$1.1M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of a drug discovery technology designed to help in the detection of toxic compounds in food products. The company's technology specializes in the generation of vectors and cells for research with optic imaging that helps in detecting toxic chemical compounds in the environment and food products, enabling clients to have the visualization of molecular events in real time and in all the organs, with high precision.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Via Einstein
  • Localit√† Cascina Codazza
  • 26900 Lodi
  • Italy

+39 0371 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Transgenic Operative Products’s full profile, request a free trial.

Transgenic Operative Products Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC $1.1M 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Transgenic Operative Products Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Finlombarda Gestioni Venture Capital Minority 000 0000 000000 0

Transgenic Operative Products Executive Team (2)

Name Title Board
Seat
Contact
Info
Adriana Maggi Co-Founder, Board Member & President
Paolo Ciana Ph.D Co-Founder, Board Member & Vice President

Transgenic Operative Products Board Members (3)

Name Representing Role Since Contact
Info
Alberto Trombetta Ph.D Finlombarda Gestioni Board Member 000 0000
Carlo Rosa Self Board Member 000 0000
Dario Casati Self Board Member 000 0000